CytoMed Therapeutics (GDTC) Total Debt (2021 - 2025)
CytoMed Therapeutics (GDTC) posted Total Debt of $315963.5 for Q4 2025, down 15.18% sequentially from $372502.0 in Q2 2025, and down 2.7% YoY from $324737.4 in Q4 2024.
CytoMed Therapeutics (GDTC) Total Debt (2021 - 2025) Analysis & Trends
CytoMed Therapeutics has reported Total Debt for 5 years, with the latest figure at $315963.5 in Q4 2025.
- Quarterly Total Debt fell 2.7% year-over-year to $315963.5 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $315963.5 (down 2.7% YoY) and the FY2025 annual result came in at $313433.1, down 2.88% from the prior year.
- Total Debt slipped to $315963.5 in Q4 2025 per GDTC's latest filing, from $372502.0 in the prior quarter.
- Over five years, Total Debt peaked at $681482.3 in Q4 2021 and troughed at $14707.0 in Q2 2023.
- A 5-year average of $377023.9 and a median of $349832.2 in 2023 frame the typical range for Total Debt.
- The sharpest annual moves came in 2023 and 2024: Total Debt slumped 43.5% in 2023, then soared 2623.8% in 2024.
- Over 5 years, Total Debt stood at $681482.3 in 2021, then retreated by 15.03% to $579047.9 in 2022, then plunged by 43.5% to $327162.4 in 2023, then dropped by 0.74% to $324737.4 in 2024, then slipped by 2.7% to $315963.5 in 2025.
- According to Business Quant data, Total Debt over the past three periods registered $315963.5, $372502.0, and $324737.4 for Q4 2025, Q2 2025, and Q4 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.54 Bn | 130.69 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.89 Bn | 77.89 Bn | 3.93 Bn | 1.99 Bn |
| 3 | Argenx Se | 64.84 Bn | 59.65 Bn | 1.37 Bn | - |
| 4 | Moderna | 56.53 Bn | 51.39 Bn | 52.00 Mn | 591.00 Mn |
| 5 | BeOne Medicines | 41.97 Bn | 36.87 Bn | 1.53 Bn | 1.07 Bn |
| 6 | Alnylam Pharmaceuticals | 31.53 Bn | 28.22 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 27.70 Bn | 9.31 Bn | 668.28 Mn | 770.36 Mn |
| 8 | Insmed | 27.45 Bn | 26.29 Bn | 358.27 Mn | 546.77 Mn |
| 9 | Royalty Pharma | 27.33 Bn | 26.49 Bn | - | 9.34 Bn |
| 10 | CytoMed Therapeutics | 9.97 Mn | 8.35 Mn | - | 315,963.49 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 315,963.49 |
| Jun 30, 2025 | 372,502.00 |
| Dec 31, 2024 | 324,737.35 |
| Jun 30, 2024 | 400,589.00 |
| Dec 31, 2023 | 327,162.38 |
| Jun 30, 2023 | 14,707.00 |
| Dec 31, 2022 | 579,047.92 |
| Dec 31, 2021 | 681,482.31 |